The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the protégé everflex nitinol stent system II (DURABILITY II)

Journal of Vascular Surgery

Volumn 58, Issue 1, 2013, Pages

  Matsumura, Jon S ^a   Yamanouchi, Dai ^a   Goldstein, Jeffrey A ^b   Pollock, Christopher W ^c   Bosiers, Marc ^d   Schultz, Greg A ^e   Scheinert, Dierk ^f   Rocha Singh, Krishna J ^g  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Prairie Cardiovascular Consultants Ltd   (United States)

^c Parkwest Medical Center   (United States)

^d A Z St Blasius   (Belgium)

^e UNIVERSITY OF SOUTH DAKOTA   (United States)

^f UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^g ST JOHN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; TICLOPIDINE;

ADULT; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; ANTICOAGULANT THERAPY; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; CLAUDICATION; CLIMBING; COMORBIDITY; DEVICE SAFETY; DIABETES MELLITUS; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; NITINOL STENT; OUTCOME ASSESSMENT; POPLITEAL ARTERY INJURY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY LESION; TREADMILL EXERCISE; TREATMENT DURATION; WALKING SPEED;

EID: 84879419559     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.12.066     Document Type: Article

References (17)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-Society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 S67
2. M. Cejna, S. Thurnher, H. Illiasch, W. Horvath, P. Waldenberger, and K. Hornik PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study J Vasc Interv Radiol 12 2001 23 31 (Pubitemid 32097991)
3. D. Vroegindeweij, L.D. Vos, A.V. Tielbeek, J. Buth, and H.C. vd Bosch Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study Cardiovasc Intervent Radiol 20 1997 420 425 (Pubitemid 27512031)
4. J. Grimm, S. Muller-Hulsbeck, T. Jahnke, C. Hilbert, J. Brossmann, and M. Heller Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions J Vasc Interv Radiol 12 2001 935 942
5. J.P. Becquemin, J.P. Favre, J. Marzelle, C. Nemoz, C. Corsin, and A. Leizorovicz Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study J Vasc Surg 37 2003 487 494 (Pubitemid 36350887)
6. Z. Zdanowski, U. Albrechtsson, A. Lundin, T. Jonung, E. Ribbe, and J. Thorne Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study Int Angiol 18 1999 251 255 (Pubitemid 30153799)
7. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888 (Pubitemid 43872689)
8. S. Sabeti, W. Mlekusch, J. Amighi, E. Minar, and M. Schillinger Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries J Endovasc Ther 12 2005 6 12 (Pubitemid 40229383)
9. H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Burgelin, D. Scheinert, and K.L. Schulte Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST) Circulation 116 2007 285 292 (Pubitemid 47196564)
10. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the resilient randomized trial Circ Cardiovasc Interv 3 2010 267 276
11. K.J. Rocha-Singh, M.R. Jaff, T.R. Crabtree, D.A. Bloch, and G. Ansel Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease Catheter Cardiovasc Interv 69 2007 910 919 (Pubitemid 46867500)
12. J. Goode, W. Sapirstein, and B. Zuckerman FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices Catheter Cardiovasc Interv 69 2007 920 921 (Pubitemid 46867501)
13. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
14. T.P. Murphy, D.E. Cutlip, J.G. Regensteiner, E.R. Mohler, D.J. Cohen, and M.R. Reynolds Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise Versus Endoluminal Revascularization (CLEVER) study Circulation 125 2012 130 139
15. D. Scheinert, S. Scheinert, J. Sax, C. Piorkowski, S. Braunlich, and M. Ulrich Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315 (Pubitemid 40094743)
16. S.H. Duda, B. Pusich, G. Richter, P. Landwehr, V.L. Oliva, and A. Tielbeek Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results Circulation 106 2002 1505 1509
17. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, and A. Tielbeek Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial J Vasc Interv Radiol 16 2005 331 338 (Pubitemid 40354849)